Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
49th Annual Meeting and Exposition of the American Society of Hematology
Extending Time to Progression in Refractory Multiple Myeloma with Novel Regimens
Atlanta, Georgia / December 8-11, 2007
Atlanta - After substantial progress in the development of more effective front-line therapies for multiple myeloma (MM), the standard for treatment of refractory disease is now also evolving. New findings indicate that meaningful...
49th Annual Meeting and Exposition of the American Society of Hematology
Clinical Challenges in Non-Hodgkin’s Lymphoma: The Use of Monoclonal Antibodies in 2008
Atlanta, Georgia / December 8-11, 2007
Studies presented at the American Society of Hematology reinforce the increasingly important role of therapies targeted at the CD20 surface protein in hematologic malignancies. In indolent non-Hodgkin’s lymphoma (NHL), final results of a...
XXIst Congress of the International Society on Thrombosis and Haemostasis
Hemostatic Control in the Challenging Surgery and Trauma Patient
Geneva, Switzerland / July 6-12, 2007
Editorial Overview Keyvan Karkouti, MD, FRCPC Staff Anesthesiologist UHN-Toronto General Hospital Associate Professor of Anesthesia University of Toronto Toronto, Ontario
2007 Annual Meeting of the Canadian Anesthesiologists’ Society
Hemostatic Therapy Advances in Trauma and Surgery
Calgary, Alberta / June 22-26, 2007
Calgary - Major bleeding substantially increases patient risk in any clinical situation, regardless of whether it is the primary problem as in hemophilia or secondary to surgery or traumatic injury. Options for controlling bleeding remain...
33rd Annual Meeting of the European Group for Blood and Marrow Transplantation
Targeted Therapy in Lymphoid Malignancies: The Changing Face of Transplantation
Lyon, France / March 25-28, 2007
Lyon - Treatment of non-Hodgkin’s lymphoma generally involves chemotherapy. Autologous or allogeneic stem cell transplantation is often considered in patients who are refractory to chemotherapy. Despite intensive research in previous...
33rd Annual Meeting of the European Group for Blood and Marrow Transplantation
Update on Antifungal Treatment Strategies in Stem Cell Transplantation
Lyon, France / March 25-28, 2007
Invasive aspergillosis is a major problem in the management of patients who have undergone stem cell transplantation (SCT). According to figures presented by Prof. Noel Milpied, University Hospital, Bordeaux, France, the incidence of these...
12th Annual Update on Cardiopulmonary Bypass
Transfusion Medicine in Cardiac Surgery: Towards Implementation of a Blood Conservation Program
Whistler, British Columbia / March 18-23, 2007
Whistler - There is an urgent need to minimize the use of all blood products in cardiac surgery, speakers here agreed, not only because blood is increasingly scarce and costly, but because transfusion itself is also associated with...
48th Annual Meeting and Exposition of the American Society of Hematology
Chronic Lymphocytic Leukemia: Novel Algorithms in Early Disease
Orlando, Florida / December 9-12, 2006
Orlando - New data suggest that both treatments and treatment goals are evolving in chronic lymphocytic leukemia (CLL). While recent studies have associated new strategies with incremental improvements in anti-CLL activity, particularly a...
48th Annual Meeting and Exposition of the American Society of Hematology
Low Molecular-weight Heparins for High-risk Patients in Context of Clot Mechanisms
Orlando, Florida / December 9-12, 2006
Orlando - The multiple mechanisms that promote venous thromboembolism (VTE) in patients with acute illnesses or cancer has been the basis for considering broader indications for prophylaxis. In a new meta-analysis of studies, low...